Amneal Pharmaceuticals

Amneal Pharmaceuticals develops, manufactures, markets, and distributes generic and specialty pharmaceutical products. Its portfolio spans various dosage forms and therapeutic areas, with a focus on complex oral solids, injectables, and branded products for central nervous system disorders. The company operates in the United States, India, Ireland, and internationally, serving wholesalers, distributors, hospitals, and pharmacies.

Gustavo Pesquin

Executive Vice President and Chief Commercial Officer

5 past transactions

Saol Therapeutics

Acquisition in 2022
Saol Therapeutics is a biotech pharmaceutical company dedicated to developing medical therapies and pharmaceutical products aimed at improving the lives of underserved patients, particularly those with rare diseases and conditions affecting the Central Nervous System. The company focuses on addressing the needs of patient populations with unmet medical needs, striving to provide effective treatments for serious and often life-threatening conditions. By prioritizing the voices of patients who may otherwise be overlooked, Saol Therapeutics is committed to delivering innovative therapies that enhance healthcare options for providers and ultimately improve patient outcomes.

Puniska Healthcare

Acquisition in 2021
Puniska Healthcare is a privately owned company dedicated to the manufacture and marketing of parenteral and injectable drugs that are critical to patient care. The company focuses on producing niche, knowledge-intensive drugs within important therapeutic segments, including analgesics, anesthetics, antiemetics, and anti-infectives. Utilizing advanced sterile and aseptic techniques, along with targeted delivery systems, Puniska Healthcare aims to deliver life-saving products to patients globally. Currently, the company is in the process of establishing a large-scale, state-of-the-art manufacturing facility to enhance its production capabilities.

Kashiv Specialty

Acquisition in 2021
Kashiv Specialty is a fully integrated pharmaceutical company that specializes in the research, development, and manufacturing of innovative medicines and advanced drug delivery technologies. The company is dedicated to creating clinically differentiated specialty pharmaceutical products and has a strong focus on lifecycle management. In addition to its proprietary product development, Kashiv Specialty provides contract research and development services to other pharmaceutical clients, offering expertise in formulation, analytical development, and clinical supply manufacturing. With a commitment to improving therapeutic options through its advanced pipeline, Kashiv Specialty is positioned as a key player in the biopharmaceutical industry.

AvKARE

Acquisition in 2019
AvKARE is a family-oriented manufacturer and wholesaler of pharmaceutical products headquartered in Pulaski, Tennessee. The company specializes in a diverse range of offerings, including medical and surgical items, laboratory supplies, biologics capital equipment, and infection control products. AvKARE serves both government and commercial sectors, focusing on meeting their medicinal needs effectively. Through a commitment to its people and a clear vision of its goals, AvKARE has developed into a thriving enterprise in the pharmaceutical industry.

Epsilon Pharmaceuticals

Acquisition in 2014
Epsilon Pharmaceuticals is a Pharmaceutical Manufacturers company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.